93 related articles for article (PubMed ID: 19828760)
1. Characterization of the functional requirements of West Nile virus membrane fusion.
Moesker B; Rodenhuis-Zybert IA; Meijerhof T; Wilschut J; Smit JM
J Gen Virol; 2010 Feb; 91(Pt 2):389-93. PubMed ID: 19828760
[TBL] [Abstract][Full Text] [Related]
2. Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system.
Corver J; Ortiz A; Allison SL; Schalich J; Heinz FX; Wilschut J
Virology; 2000 Mar; 269(1):37-46. PubMed ID: 10725196
[TBL] [Abstract][Full Text] [Related]
3. Characterization of plasma membrane-associated proteins from Aedes albopictus mosquito (C6/36) cells that mediate West Nile virus binding and infection.
Chu JJ; Leong PW; Ng ML
Virology; 2005 Sep; 339(2):249-60. PubMed ID: 15992848
[TBL] [Abstract][Full Text] [Related]
4. pH-dependent fusion between the flavivirus West Nile and liposomal model membranes.
Gollins SW; Porterfield JS
J Gen Virol; 1986 Jan; 67 ( Pt 1)():157-66. PubMed ID: 3944582
[TBL] [Abstract][Full Text] [Related]
5. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
[TBL] [Abstract][Full Text] [Related]
6. West Nile virus and kidney disease.
Barzon L; Pacenti M; Palù G
Expert Rev Anti Infect Ther; 2013 May; 11(5):479-87. PubMed ID: 23627854
[TBL] [Abstract][Full Text] [Related]
7. Evidence that rabies virus forms different kinds of fusion machines with different pH thresholds for fusion.
Roche S; Gaudin Y
J Virol; 2004 Aug; 78(16):8746-52. PubMed ID: 15280482
[TBL] [Abstract][Full Text] [Related]
8. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.
Jordan I; Briese T; Fischer N; Lau JY; Lipkin WI
J Infect Dis; 2000 Oct; 182(4):1214-7. PubMed ID: 10979920
[TBL] [Abstract][Full Text] [Related]
9. Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway.
Ramanathan MP; Chambers JA; Pankhong P; Chattergoon M; Attatippaholkun W; Dang K; Shah N; Weiner DB
Virology; 2006 Feb; 345(1):56-72. PubMed ID: 16243374
[TBL] [Abstract][Full Text] [Related]
10. Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.
Rossi SL; Zhao Q; O'Donnell VK; Mason PW
Virology; 2005 Jan; 331(2):457-70. PubMed ID: 15629788
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of subgenomic replicons of New York strain of West Nile virus.
Shi PY; Tilgner M; Lo MK
Virology; 2002 May; 296(2):219-33. PubMed ID: 12069521
[TBL] [Abstract][Full Text] [Related]
12. DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.
Martina BE; Koraka P; van den Doel P; Rimmelzwaan GF; Haagmans BL; Osterhaus AD
Virus Res; 2008 Jul; 135(1):64-71. PubMed ID: 18405996
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
14. Replication of West Nile virus in equine peripheral blood mononuclear cells.
Garcia-Tapia D; Loiacono CM; Kleiboeker SB
Vet Immunol Immunopathol; 2006 Apr; 110(3-4):229-44. PubMed ID: 16310859
[TBL] [Abstract][Full Text] [Related]
15. The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion.
Epand RF; Macosko JC; Russell CJ; Shin YK; Epand RM
J Mol Biol; 1999 Feb; 286(2):489-503. PubMed ID: 9973566
[TBL] [Abstract][Full Text] [Related]
16. West Nile virus-induced pancreatitis.
Buber J; Fink N; Bin H; Mouallem M
Travel Med Infect Dis; 2008 Nov; 6(6):373-5. PubMed ID: 18984483
[TBL] [Abstract][Full Text] [Related]
17. Association between the pH-dependent conformational change of West Nile flavivirus E protein and virus-mediated membrane fusion.
Kimura T; Ohyama A
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1247-54. PubMed ID: 3385406
[TBL] [Abstract][Full Text] [Related]
18. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
[TBL] [Abstract][Full Text] [Related]
19. Antiviral peptides targeting the west nile virus envelope protein.
Bai F; Town T; Pradhan D; Cox J; Ashish ; Ledizet M; Anderson JF; Flavell RA; Krueger JK; Koski RA; Fikrig E
J Virol; 2007 Feb; 81(4):2047-55. PubMed ID: 17151121
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
Samina I; Havenga M; Koudstaal W; Khinich Y; Koldijk M; Malkinson M; Simanov M; Perl S; Gijsbers L; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2007 Nov; 25(49):8338-45. PubMed ID: 17977629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
